Across TCGA pan-cancer cohorts, MRPL20P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MRPL20P1 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MRPL20P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MRPL20P1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CESC show a favorable association.
LUAD, KIRC, and MESO are the cancer types where MRPL20P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.